Immune Evasion of Hepatoma Cancer Stem-Like Cells from Natural Killer Cells

Background Poor prognosis in liver cancer is due to its high frequency of intrahepatic metastasis. Cancer stem-like cells (CSLCs), which possess the properties of stemness, tumor initiation capability, and resistance to therapy, also exhibit metastatic potential. Immune surveillance plays an importa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of surgical oncology 2022-11, Vol.29 (12), p.7423-7433
Hauptverfasser: Kimura, Yuta, Tsunedomi, Ryouichi, Yoshimura, Kiyoshi, Matsukuma, Satoshi, Shindo, Yoshitaro, Matsui, Hiroto, Tokumitsu, Yukio, Yoshida, Shin, Iida, Michihisa, Suzuki, Nobuaki, Takeda, Shigeru, Ioka, Tatsuya, Hazama, Shoichi, Nagano, Hiroaki
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 7433
container_issue 12
container_start_page 7423
container_title Annals of surgical oncology
container_volume 29
creator Kimura, Yuta
Tsunedomi, Ryouichi
Yoshimura, Kiyoshi
Matsukuma, Satoshi
Shindo, Yoshitaro
Matsui, Hiroto
Tokumitsu, Yukio
Yoshida, Shin
Iida, Michihisa
Suzuki, Nobuaki
Takeda, Shigeru
Ioka, Tatsuya
Hazama, Shoichi
Nagano, Hiroaki
description Background Poor prognosis in liver cancer is due to its high frequency of intrahepatic metastasis. Cancer stem-like cells (CSLCs), which possess the properties of stemness, tumor initiation capability, and resistance to therapy, also exhibit metastatic potential. Immune surveillance plays an important role in the accomplishment of metastasis. Herein, the property of immune evasion in CSLCs was investigated. Methods Sphere cells were induced as CSLCs using a sphere induction medium containing neural survival factor-1. The expression of genes involved in immune evasion was determined using RNA-sequencing for sphere and parental cells followed by validation using flow cytometric analysis and ELISA. Susceptibility to natural killer (NK) cell-mediated cytotoxicity was examined by a chromium release assay. A xenograft model using BALB/c nu/nu mice was used to assess tumor growth. Gene set enrichment analysis was performed for interpreting RNA sequencing. Results The cell surface expressions of PD-L1, PD-L2, and CEACAM1 were upregulated and those of ULBP1 and MICA/MICB were downregulated in SK-sphere, CSLCs derived from SK-HEP-1, compared with that in parental cells. Levels of soluble MICA were elevated in conditioned medium from SK-sphere. Expression of HLA class I was not downregulated in SK-sphere. The susceptibilities to NK cell-mediated killing and secreted perforin were significantly lower in both CSLCs derived from SK-HEP-1 and HLE than in parental cells. Tumors formed upon inoculation of SK-sphere in immunodeficient mice harboring NK cells were larger than those formed upon inoculation of parental cells. Conclusion Human hepatoma cell line-derived CSLCs may possess immune evasion properties, especially from NK cell-mediated immunity.
doi_str_mv 10.1245/s10434-022-12220-w
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2694415627</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2694415627</sourcerecordid><originalsourceid>FETCH-LOGICAL-c418t-270a4a7e468acf9162e2271ba2b9fb534e4cda92159a8585279bf55c28372e33</originalsourceid><addsrcrecordid>eNp9kDFPwzAQhS0EEqXwB5gssbAY7IsdJyOqCq1awUB3ywkXlJLExU6o-PeYBgmJgelOd997enqEXAp-I0Cq2yC4TCTjAEwAAGf7IzIRKp5kmonjuPM0Yzmk6pSchbDlXOiEqwlZLdt26JDOP2yoXUddRRe4s71rLZ3ZrkRPn3ts2bp-QzrDpgm08q6lj7YfvG3oqm6ayBw-5-Sksk3Ai585JZv7-Wa2YOunh-Xsbs1KKbKegeZWWo0xmS2rXKSAAFoUFoq8KmJmlOWLzUGo3GYqU6DzolKqhCzRgEkyJdej7c679wFDb9o6lDGA7dANwUCaSylUCjqiV3_QrRt8F8MZ0JBER1AyUjBSpXcheKzMztet9Z9GcPNdrxnrNbFec6jX7KMoGUUhwt0r-l_rf1Rf2UZ7eg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2723283254</pqid></control><display><type>article</type><title>Immune Evasion of Hepatoma Cancer Stem-Like Cells from Natural Killer Cells</title><source>SpringerLink Journals - AutoHoldings</source><creator>Kimura, Yuta ; Tsunedomi, Ryouichi ; Yoshimura, Kiyoshi ; Matsukuma, Satoshi ; Shindo, Yoshitaro ; Matsui, Hiroto ; Tokumitsu, Yukio ; Yoshida, Shin ; Iida, Michihisa ; Suzuki, Nobuaki ; Takeda, Shigeru ; Ioka, Tatsuya ; Hazama, Shoichi ; Nagano, Hiroaki</creator><creatorcontrib>Kimura, Yuta ; Tsunedomi, Ryouichi ; Yoshimura, Kiyoshi ; Matsukuma, Satoshi ; Shindo, Yoshitaro ; Matsui, Hiroto ; Tokumitsu, Yukio ; Yoshida, Shin ; Iida, Michihisa ; Suzuki, Nobuaki ; Takeda, Shigeru ; Ioka, Tatsuya ; Hazama, Shoichi ; Nagano, Hiroaki</creatorcontrib><description>Background Poor prognosis in liver cancer is due to its high frequency of intrahepatic metastasis. Cancer stem-like cells (CSLCs), which possess the properties of stemness, tumor initiation capability, and resistance to therapy, also exhibit metastatic potential. Immune surveillance plays an important role in the accomplishment of metastasis. Herein, the property of immune evasion in CSLCs was investigated. Methods Sphere cells were induced as CSLCs using a sphere induction medium containing neural survival factor-1. The expression of genes involved in immune evasion was determined using RNA-sequencing for sphere and parental cells followed by validation using flow cytometric analysis and ELISA. Susceptibility to natural killer (NK) cell-mediated cytotoxicity was examined by a chromium release assay. A xenograft model using BALB/c nu/nu mice was used to assess tumor growth. Gene set enrichment analysis was performed for interpreting RNA sequencing. Results The cell surface expressions of PD-L1, PD-L2, and CEACAM1 were upregulated and those of ULBP1 and MICA/MICB were downregulated in SK-sphere, CSLCs derived from SK-HEP-1, compared with that in parental cells. Levels of soluble MICA were elevated in conditioned medium from SK-sphere. Expression of HLA class I was not downregulated in SK-sphere. The susceptibilities to NK cell-mediated killing and secreted perforin were significantly lower in both CSLCs derived from SK-HEP-1 and HLE than in parental cells. Tumors formed upon inoculation of SK-sphere in immunodeficient mice harboring NK cells were larger than those formed upon inoculation of parental cells. Conclusion Human hepatoma cell line-derived CSLCs may possess immune evasion properties, especially from NK cell-mediated immunity.</description><identifier>ISSN: 1068-9265</identifier><identifier>EISSN: 1534-4681</identifier><identifier>DOI: 10.1245/s10434-022-12220-w</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Cancer ; CD66 antigen ; CEACAM1 protein ; Cell surface ; Cell-mediated immunity ; Cytotoxicity ; Enzyme-linked immunosorbent assay ; Flow cytometry ; Gene set enrichment analysis ; Hepatoma ; Histocompatibility antigen HLA ; Immune evasion ; Immunodeficiency ; Immunosurveillance ; Inoculation ; Liver cancer ; Major histocompatibility complex ; Medical prognosis ; Medicine ; Medicine &amp; Public Health ; Metastases ; Metastasis ; Natural killer cells ; Oncology ; PD-L1 protein ; Perforin ; Surgery ; Surgical Oncology ; Survival factor ; Translational Research ; Xenografts</subject><ispartof>Annals of surgical oncology, 2022-11, Vol.29 (12), p.7423-7433</ispartof><rights>Society of Surgical Oncology 2022</rights><rights>Society of Surgical Oncology 2022.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c418t-270a4a7e468acf9162e2271ba2b9fb534e4cda92159a8585279bf55c28372e33</citedby><cites>FETCH-LOGICAL-c418t-270a4a7e468acf9162e2271ba2b9fb534e4cda92159a8585279bf55c28372e33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1245/s10434-022-12220-w$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1245/s10434-022-12220-w$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids></links><search><creatorcontrib>Kimura, Yuta</creatorcontrib><creatorcontrib>Tsunedomi, Ryouichi</creatorcontrib><creatorcontrib>Yoshimura, Kiyoshi</creatorcontrib><creatorcontrib>Matsukuma, Satoshi</creatorcontrib><creatorcontrib>Shindo, Yoshitaro</creatorcontrib><creatorcontrib>Matsui, Hiroto</creatorcontrib><creatorcontrib>Tokumitsu, Yukio</creatorcontrib><creatorcontrib>Yoshida, Shin</creatorcontrib><creatorcontrib>Iida, Michihisa</creatorcontrib><creatorcontrib>Suzuki, Nobuaki</creatorcontrib><creatorcontrib>Takeda, Shigeru</creatorcontrib><creatorcontrib>Ioka, Tatsuya</creatorcontrib><creatorcontrib>Hazama, Shoichi</creatorcontrib><creatorcontrib>Nagano, Hiroaki</creatorcontrib><title>Immune Evasion of Hepatoma Cancer Stem-Like Cells from Natural Killer Cells</title><title>Annals of surgical oncology</title><addtitle>Ann Surg Oncol</addtitle><description>Background Poor prognosis in liver cancer is due to its high frequency of intrahepatic metastasis. Cancer stem-like cells (CSLCs), which possess the properties of stemness, tumor initiation capability, and resistance to therapy, also exhibit metastatic potential. Immune surveillance plays an important role in the accomplishment of metastasis. Herein, the property of immune evasion in CSLCs was investigated. Methods Sphere cells were induced as CSLCs using a sphere induction medium containing neural survival factor-1. The expression of genes involved in immune evasion was determined using RNA-sequencing for sphere and parental cells followed by validation using flow cytometric analysis and ELISA. Susceptibility to natural killer (NK) cell-mediated cytotoxicity was examined by a chromium release assay. A xenograft model using BALB/c nu/nu mice was used to assess tumor growth. Gene set enrichment analysis was performed for interpreting RNA sequencing. Results The cell surface expressions of PD-L1, PD-L2, and CEACAM1 were upregulated and those of ULBP1 and MICA/MICB were downregulated in SK-sphere, CSLCs derived from SK-HEP-1, compared with that in parental cells. Levels of soluble MICA were elevated in conditioned medium from SK-sphere. Expression of HLA class I was not downregulated in SK-sphere. The susceptibilities to NK cell-mediated killing and secreted perforin were significantly lower in both CSLCs derived from SK-HEP-1 and HLE than in parental cells. Tumors formed upon inoculation of SK-sphere in immunodeficient mice harboring NK cells were larger than those formed upon inoculation of parental cells. Conclusion Human hepatoma cell line-derived CSLCs may possess immune evasion properties, especially from NK cell-mediated immunity.</description><subject>Cancer</subject><subject>CD66 antigen</subject><subject>CEACAM1 protein</subject><subject>Cell surface</subject><subject>Cell-mediated immunity</subject><subject>Cytotoxicity</subject><subject>Enzyme-linked immunosorbent assay</subject><subject>Flow cytometry</subject><subject>Gene set enrichment analysis</subject><subject>Hepatoma</subject><subject>Histocompatibility antigen HLA</subject><subject>Immune evasion</subject><subject>Immunodeficiency</subject><subject>Immunosurveillance</subject><subject>Inoculation</subject><subject>Liver cancer</subject><subject>Major histocompatibility complex</subject><subject>Medical prognosis</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Metastases</subject><subject>Metastasis</subject><subject>Natural killer cells</subject><subject>Oncology</subject><subject>PD-L1 protein</subject><subject>Perforin</subject><subject>Surgery</subject><subject>Surgical Oncology</subject><subject>Survival factor</subject><subject>Translational Research</subject><subject>Xenografts</subject><issn>1068-9265</issn><issn>1534-4681</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNp9kDFPwzAQhS0EEqXwB5gssbAY7IsdJyOqCq1awUB3ywkXlJLExU6o-PeYBgmJgelOd997enqEXAp-I0Cq2yC4TCTjAEwAAGf7IzIRKp5kmonjuPM0Yzmk6pSchbDlXOiEqwlZLdt26JDOP2yoXUddRRe4s71rLZ3ZrkRPn3ts2bp-QzrDpgm08q6lj7YfvG3oqm6ayBw-5-Sksk3Ai585JZv7-Wa2YOunh-Xsbs1KKbKegeZWWo0xmS2rXKSAAFoUFoq8KmJmlOWLzUGo3GYqU6DzolKqhCzRgEkyJdej7c679wFDb9o6lDGA7dANwUCaSylUCjqiV3_QrRt8F8MZ0JBER1AyUjBSpXcheKzMztet9Z9GcPNdrxnrNbFec6jX7KMoGUUhwt0r-l_rf1Rf2UZ7eg</recordid><startdate>20221101</startdate><enddate>20221101</enddate><creator>Kimura, Yuta</creator><creator>Tsunedomi, Ryouichi</creator><creator>Yoshimura, Kiyoshi</creator><creator>Matsukuma, Satoshi</creator><creator>Shindo, Yoshitaro</creator><creator>Matsui, Hiroto</creator><creator>Tokumitsu, Yukio</creator><creator>Yoshida, Shin</creator><creator>Iida, Michihisa</creator><creator>Suzuki, Nobuaki</creator><creator>Takeda, Shigeru</creator><creator>Ioka, Tatsuya</creator><creator>Hazama, Shoichi</creator><creator>Nagano, Hiroaki</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20221101</creationdate><title>Immune Evasion of Hepatoma Cancer Stem-Like Cells from Natural Killer Cells</title><author>Kimura, Yuta ; Tsunedomi, Ryouichi ; Yoshimura, Kiyoshi ; Matsukuma, Satoshi ; Shindo, Yoshitaro ; Matsui, Hiroto ; Tokumitsu, Yukio ; Yoshida, Shin ; Iida, Michihisa ; Suzuki, Nobuaki ; Takeda, Shigeru ; Ioka, Tatsuya ; Hazama, Shoichi ; Nagano, Hiroaki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c418t-270a4a7e468acf9162e2271ba2b9fb534e4cda92159a8585279bf55c28372e33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Cancer</topic><topic>CD66 antigen</topic><topic>CEACAM1 protein</topic><topic>Cell surface</topic><topic>Cell-mediated immunity</topic><topic>Cytotoxicity</topic><topic>Enzyme-linked immunosorbent assay</topic><topic>Flow cytometry</topic><topic>Gene set enrichment analysis</topic><topic>Hepatoma</topic><topic>Histocompatibility antigen HLA</topic><topic>Immune evasion</topic><topic>Immunodeficiency</topic><topic>Immunosurveillance</topic><topic>Inoculation</topic><topic>Liver cancer</topic><topic>Major histocompatibility complex</topic><topic>Medical prognosis</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Metastases</topic><topic>Metastasis</topic><topic>Natural killer cells</topic><topic>Oncology</topic><topic>PD-L1 protein</topic><topic>Perforin</topic><topic>Surgery</topic><topic>Surgical Oncology</topic><topic>Survival factor</topic><topic>Translational Research</topic><topic>Xenografts</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kimura, Yuta</creatorcontrib><creatorcontrib>Tsunedomi, Ryouichi</creatorcontrib><creatorcontrib>Yoshimura, Kiyoshi</creatorcontrib><creatorcontrib>Matsukuma, Satoshi</creatorcontrib><creatorcontrib>Shindo, Yoshitaro</creatorcontrib><creatorcontrib>Matsui, Hiroto</creatorcontrib><creatorcontrib>Tokumitsu, Yukio</creatorcontrib><creatorcontrib>Yoshida, Shin</creatorcontrib><creatorcontrib>Iida, Michihisa</creatorcontrib><creatorcontrib>Suzuki, Nobuaki</creatorcontrib><creatorcontrib>Takeda, Shigeru</creatorcontrib><creatorcontrib>Ioka, Tatsuya</creatorcontrib><creatorcontrib>Hazama, Shoichi</creatorcontrib><creatorcontrib>Nagano, Hiroaki</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of surgical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kimura, Yuta</au><au>Tsunedomi, Ryouichi</au><au>Yoshimura, Kiyoshi</au><au>Matsukuma, Satoshi</au><au>Shindo, Yoshitaro</au><au>Matsui, Hiroto</au><au>Tokumitsu, Yukio</au><au>Yoshida, Shin</au><au>Iida, Michihisa</au><au>Suzuki, Nobuaki</au><au>Takeda, Shigeru</au><au>Ioka, Tatsuya</au><au>Hazama, Shoichi</au><au>Nagano, Hiroaki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immune Evasion of Hepatoma Cancer Stem-Like Cells from Natural Killer Cells</atitle><jtitle>Annals of surgical oncology</jtitle><stitle>Ann Surg Oncol</stitle><date>2022-11-01</date><risdate>2022</risdate><volume>29</volume><issue>12</issue><spage>7423</spage><epage>7433</epage><pages>7423-7433</pages><issn>1068-9265</issn><eissn>1534-4681</eissn><abstract>Background Poor prognosis in liver cancer is due to its high frequency of intrahepatic metastasis. Cancer stem-like cells (CSLCs), which possess the properties of stemness, tumor initiation capability, and resistance to therapy, also exhibit metastatic potential. Immune surveillance plays an important role in the accomplishment of metastasis. Herein, the property of immune evasion in CSLCs was investigated. Methods Sphere cells were induced as CSLCs using a sphere induction medium containing neural survival factor-1. The expression of genes involved in immune evasion was determined using RNA-sequencing for sphere and parental cells followed by validation using flow cytometric analysis and ELISA. Susceptibility to natural killer (NK) cell-mediated cytotoxicity was examined by a chromium release assay. A xenograft model using BALB/c nu/nu mice was used to assess tumor growth. Gene set enrichment analysis was performed for interpreting RNA sequencing. Results The cell surface expressions of PD-L1, PD-L2, and CEACAM1 were upregulated and those of ULBP1 and MICA/MICB were downregulated in SK-sphere, CSLCs derived from SK-HEP-1, compared with that in parental cells. Levels of soluble MICA were elevated in conditioned medium from SK-sphere. Expression of HLA class I was not downregulated in SK-sphere. The susceptibilities to NK cell-mediated killing and secreted perforin were significantly lower in both CSLCs derived from SK-HEP-1 and HLE than in parental cells. Tumors formed upon inoculation of SK-sphere in immunodeficient mice harboring NK cells were larger than those formed upon inoculation of parental cells. Conclusion Human hepatoma cell line-derived CSLCs may possess immune evasion properties, especially from NK cell-mediated immunity.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><doi>10.1245/s10434-022-12220-w</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1068-9265
ispartof Annals of surgical oncology, 2022-11, Vol.29 (12), p.7423-7433
issn 1068-9265
1534-4681
language eng
recordid cdi_proquest_miscellaneous_2694415627
source SpringerLink Journals - AutoHoldings
subjects Cancer
CD66 antigen
CEACAM1 protein
Cell surface
Cell-mediated immunity
Cytotoxicity
Enzyme-linked immunosorbent assay
Flow cytometry
Gene set enrichment analysis
Hepatoma
Histocompatibility antigen HLA
Immune evasion
Immunodeficiency
Immunosurveillance
Inoculation
Liver cancer
Major histocompatibility complex
Medical prognosis
Medicine
Medicine & Public Health
Metastases
Metastasis
Natural killer cells
Oncology
PD-L1 protein
Perforin
Surgery
Surgical Oncology
Survival factor
Translational Research
Xenografts
title Immune Evasion of Hepatoma Cancer Stem-Like Cells from Natural Killer Cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T07%3A52%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immune%20Evasion%20of%20Hepatoma%20Cancer%20Stem-Like%20Cells%20from%20Natural%20Killer%20Cells&rft.jtitle=Annals%20of%20surgical%20oncology&rft.au=Kimura,%20Yuta&rft.date=2022-11-01&rft.volume=29&rft.issue=12&rft.spage=7423&rft.epage=7433&rft.pages=7423-7433&rft.issn=1068-9265&rft.eissn=1534-4681&rft_id=info:doi/10.1245/s10434-022-12220-w&rft_dat=%3Cproquest_cross%3E2694415627%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2723283254&rft_id=info:pmid/&rfr_iscdi=true